STAAR Surgical Company Forecast, price target & analysts
STAAR Surgical Company Target price 2025 - Analyst rating & recommendation
STAAR Surgical Company Classifications & Recommendation:
STAAR Surgical Company Price Target
| Target Price | $18.67 |
| Price | $17.69 |
| Potential |
5.52%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target STAAR Surgical Company 2026 .
The average STAAR Surgical Company target price is $18.67.
This is
5.52%
register free of charge
$27.00
52.63%
register free of charge
$13.00
26.51%
register free of charge
|
|
| A rating was issued by 13 analysts: 3 Analysts recommend STAAR Surgical Company to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the STAAR Surgical Company stock has an average upside potential 2026 of
5.52%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 313.90 | 260.72 |
| 2.64% | 16.94% | |
| EBITDA Margin | -1.82% | -13.91% |
| 117.69% | 663.35% | |
| Net Margin | -6.44% | -26.45% |
| 197.94% | 310.84% |
13 Analysts have issued a sales forecast STAAR Surgical Company 2025 . The average STAAR Surgical Company sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an STAAR Surgical Company EBITDA forecast 2025. The average STAAR Surgical Company EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 STAAR Surgical Company Analysts have issued a net profit forecast 2025. The average STAAR Surgical Company net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.41 | -1.40 |
| 195.35% | 241.46% | |
| P/E | negative | |
| EV/Sales | 2.61 |
10 Analysts have issued a STAAR Surgical Company forecast for earnings per share. The average STAAR Surgical Company <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the STAAR Surgical Company stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
STAAR Surgical Company...
Current STAAR Surgical Company Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham | Locked ➜ Locked | Locked | Feb 27 2025 |
| Canaccord Genuity | Locked ➜ Locked | Locked | Feb 13 2025 |
| Stifel | Locked ➜ Locked | Locked | Feb 12 2025 |
| William Blair | Locked ➜ Locked | Locked | Feb 12 2025 |
| Piper Sandler | Locked ➜ Locked | Locked | Feb 12 2025 |
| Stephens & Co. | Locked ➜ Locked | Locked | Feb 12 2025 |
| Needham | Locked ➜ Locked | Locked | Feb 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham: Locked ➜ Locked
|
Feb 27 2025 |
|
Locked
Canaccord Genuity: Locked ➜ Locked
|
Feb 13 2025 |
|
Locked
Stifel: Locked ➜ Locked
|
Feb 12 2025 |
|
Locked
William Blair: Locked ➜ Locked
|
Feb 12 2025 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Feb 12 2025 |
|
Locked
Stephens & Co.: Locked ➜ Locked
|
Feb 12 2025 |
|
Locked
Needham: Locked ➜ Locked
|
Feb 12 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
